LINC00882

Across TCGA pan-cancer cohorts, LINC00882 RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of LINC00882’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where LINC00882 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00882 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, KIRC, and BLCA are the cancer types where LINC00882 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00882 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.778	<.001	11	view →
KIRC	Male	II,III,IV	−0.755	<.001	10	view →
BLCA	All	All	−0.446	<.001	8	view →
KICH	Male	All	−1.392	<.001	7	view →
UCEC	All	II,III,IV	−0.917	<.001	6	view →
BRCA	All	III,IV	−0.336	<.001	6	view →
COAD	All	All	−0.125	.001	6	view →
STAD	All	All	−0.345	.001	5	view →
KIRP	Male	All	−0.628	.001	4	view →
LIHC	All	All	+0.051	.005	4	view →
PRAD	All	All	−0.459	<.001	2	view →
READ	All	All	−0.278	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

LINC00882–THCA

Open the THCA breakdown →